Proteomic analysis of integral plasma membrane proteins

Area of Science:

• Proteomics
• Cell Biology
• Biochemistry

Background:

• Profiling integral plasma membrane proteins is crucial for understanding disease mechanisms and identifying therapeutic targets.
• Current methods often suffer from contamination by cytosolic proteins and subcellular organelles.
• Efficient and pure isolation of plasma membrane proteins is essential for accurate proteomic analysis.

Purpose of the Study:

• To develop and validate an efficient method for the proteomic analysis of integral plasma membrane proteins.
• To identify overexpressed proteins in disease cells for potential therapeutic monoclonal antibody development.
• To improve the purity of plasma membrane protein preparations by minimizing contamination.

Main Methods:

• Developed a biotin-directed affinity purification (BDAP) method.
• Involved cell surface biotinylation, streptavidin bead enrichment, and harsh buffer washes for cytosolic protein depletion.
• Utilized SDS-PAGE, HPLC/MS/MS for protein separation and identification.

Main Results:

• The BDAP method effectively purified integral plasma membrane proteins from a human lung cancer cell line.
• Western blotting confirmed near-complete absence of the cytosolic protein actin.
• Nano-HPLC/MS/MS identified 898 unique proteins, with 526 (67.3%) confirmed as integral plasma membrane proteins, including prenylated and Ras family proteins.

Conclusions:

• The BDAP method provides a highly efficient and comprehensive approach for integral plasma membrane proteome analysis.
• This technique significantly advances the characterization of plasma membrane subproteomes.
• It facilitates the discovery of novel plasma membrane protein drug targets for therapeutic applications.